|
1
|
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
|
J Clin Oncol
|
2013
|
3.76
|
|
2
|
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.
|
J Clin Oncol
|
2013
|
3.70
|
|
3
|
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.
|
Int J Radiat Oncol Biol Phys
|
2002
|
3.39
|
|
4
|
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
|
J Clin Oncol
|
2008
|
3.02
|
|
5
|
Phase I study of individualized stereotactic body radiotherapy of liver metastases.
|
J Clin Oncol
|
2009
|
2.78
|
|
6
|
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
|
J Clin Oncol
|
2009
|
2.74
|
|
7
|
Radiation dose-volume effects in the stomach and small bowel.
|
Int J Radiat Oncol Biol Phys
|
2010
|
2.69
|
|
8
|
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
|
J Clin Oncol
|
2006
|
2.49
|
|
9
|
Radiation-associated liver injury.
|
Int J Radiat Oncol Biol Phys
|
2010
|
2.39
|
|
10
|
Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations.
|
Acta Oncol
|
2009
|
2.33
|
|
11
|
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
|
J Clin Oncol
|
2005
|
2.20
|
|
12
|
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
|
Int J Radiat Oncol Biol Phys
|
2004
|
2.00
|
|
13
|
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
|
Oral Oncol
|
2012
|
1.98
|
|
14
|
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
|
Cancer
|
2011
|
1.87
|
|
15
|
Radiotherapy for liver metastases: a review of evidence.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.85
|
|
16
|
Assessment of a model-based deformable image registration approach for radiation therapy planning.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.75
|
|
17
|
Radiation therapy for hepatocellular carcinoma: from palliation to cure.
|
Cancer
|
2006
|
1.71
|
|
18
|
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.70
|
|
19
|
Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.67
|
|
20
|
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.55
|
|
21
|
Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.47
|
|
22
|
Response to letter to the editor with reference to article "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure".
|
Oral Oncol
|
2013
|
1.40
|
|
23
|
Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.39
|
|
24
|
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.
|
Oral Oncol
|
2012
|
1.38
|
|
25
|
Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
|
World J Surg
|
2003
|
1.28
|
|
26
|
Local surgical, ablative, and radiation treatment of metastases.
|
CA Cancer J Clin
|
2009
|
1.28
|
|
27
|
Image-guided radiotherapy: has it influenced patient outcomes?
|
Semin Radiat Oncol
|
2012
|
1.23
|
|
28
|
Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.18
|
|
29
|
The role of local therapy in the management of lung and liver oligometastases.
|
Nat Rev Clin Oncol
|
2011
|
1.17
|
|
30
|
Adapting population liver motion models for individualized online image-guided therapy.
|
Conf Proc IEEE Eng Med Biol Soc
|
2008
|
1.16
|
|
31
|
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.
|
Cancer
|
2013
|
1.16
|
|
32
|
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.
|
Radiother Oncol
|
2012
|
1.12
|
|
33
|
Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.11
|
|
34
|
Radiotherapy for hepatocellular carcinoma: an overview.
|
Ann Surg Oncol
|
2008
|
1.10
|
|
35
|
Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.10
|
|
36
|
Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.09
|
|
37
|
Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.07
|
|
38
|
Improving image-guided target localization through deformable registration.
|
Acta Oncol
|
2008
|
1.07
|
|
39
|
Cone-beam CT assessment of interfraction and intrafraction setup error of two head-and-neck cancer thermoplastic masks.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.06
|
|
40
|
Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.06
|
|
41
|
Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.03
|
|
42
|
Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.03
|
|
43
|
Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.02
|
|
44
|
Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.01
|
|
45
|
Alterations in normal liver doses due to organ motion.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.00
|
|
46
|
Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.98
|
|
47
|
MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study.
|
Radiology
|
2010
|
0.98
|
|
48
|
Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.97
|
|
49
|
Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.96
|
|
50
|
Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer.
|
Head Neck
|
2007
|
0.94
|
|
51
|
Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.
|
Transpl Int
|
2009
|
0.92
|
|
52
|
Daily prostate targeting using implanted radiopaque markers.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.91
|
|
53
|
Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.91
|
|
54
|
Three-dimensional motion of liver tumors using cine-magnetic resonance imaging.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.90
|
|
55
|
An international survey on liver metastases radiotherapy.
|
Acta Oncol
|
2012
|
0.89
|
|
56
|
Stereotactic body radiation therapy for hepatocellular carcinoma.
|
Discov Med
|
2010
|
0.89
|
|
57
|
Protons or photons for hepatocellular carcinoma? Let's move forward together.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.89
|
|
58
|
Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.89
|
|
59
|
Upper abdominal malignancies: intensity-modulated radiation therapy.
|
Front Radiat Ther Oncol
|
2007
|
0.88
|
|
60
|
Emerging role of radiotherapy in the management of liver metastases.
|
Cancer J
|
2010
|
0.88
|
|
61
|
Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib.
|
Anticancer Drugs
|
2010
|
0.88
|
|
62
|
Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.87
|
|
63
|
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer.
|
Radiother Oncol
|
2005
|
0.86
|
|
64
|
Malignant intracardiac thrombus from hepatocellular carcinoma treated with external beam radiation therapy.
|
J Palliat Med
|
2010
|
0.84
|
|
65
|
Long term control of a maxillary sinus mucoepidermoid carcinoma with low dose radiation therapy: a case report.
|
Radiat Oncol
|
2013
|
0.84
|
|
66
|
Neoadjuvant treatment for pancreatic cancer--a review.
|
Crit Rev Oncol Hematol
|
2007
|
0.84
|
|
67
|
Truths and myths about radiotherapy for verrucous carcinoma of larynx.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.84
|
|
68
|
Image-guided radiotherapy strategies in upper gastrointestinal malignancies.
|
Front Radiat Ther Oncol
|
2011
|
0.83
|
|
69
|
Accumulated dose in liver stereotactic body radiotherapy: positioning, breathing, and deformation effects.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.83
|
|
70
|
Daily targeting of intrahepatic tumors for radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.82
|
|
71
|
Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma.
|
J Gastrointest Cancer
|
2012
|
0.81
|
|
72
|
Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
|
Head Neck
|
2014
|
0.80
|
|
73
|
Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases.
|
J Clin Oncol
|
2013
|
0.80
|
|
74
|
Cancer of the gallbladder and extrahepatic bile ducts.
|
Curr Probl Surg
|
2007
|
0.80
|
|
75
|
Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.79
|
|
76
|
Squamous cell carcinoma arising in a proliferating pilar (trichilemmal) cyst with nodal and distant metastases.
|
J Otolaryngol Head Neck Surg
|
2010
|
0.78
|
|
77
|
Lack of influence of intravenous contrast on head and neck IMRT dose distributions.
|
Acta Oncol
|
2008
|
0.78
|
|
78
|
Point-of-care outcome assessment in the cancer clinic: audit of data quality.
|
Radiother Oncol
|
2010
|
0.78
|
|
79
|
Dosimetric analysis of radiation-induced gastric bleeding.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.78
|
|
80
|
Outcome of adjuvant therapy in biliary tract cancers.
|
Am J Clin Oncol
|
2015
|
0.77
|
|
81
|
Options for radiotherapy in the treatment of liver metastases.
|
Clin Transl Oncol
|
2008
|
0.77
|
|
82
|
Image guidance and the new practice of radiotherapy: what to know and use from a decade of investigation.
|
Front Radiat Ther Oncol
|
2011
|
0.77
|
|
83
|
In reply to letter to the editor by Dr Willems et al. re: Eccles et al. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations.
|
Acta Oncol
|
2010
|
0.76
|
|
84
|
Adaptive management of liver cancer radiotherapy.
|
Semin Radiat Oncol
|
2010
|
0.76
|
|
85
|
A pragmatic contouring guideline for salivary gland structures in head and neck radiation oncology: the MOIST target.
|
Am J Clin Oncol
|
2013
|
0.76
|
|
86
|
Safety considerations for IGRT: Executive summary.
|
Pract Radiat Oncol
|
2013
|
0.76
|
|
87
|
Comparison of simple and complex liver intensity modulated radiotherapy.
|
Radiat Oncol
|
2010
|
0.75
|
|
88
|
Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 2006;65:189-195).
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.75
|
|
89
|
Case 23-2005: a man with a mass in the liver.
|
N Engl J Med
|
2005
|
0.75
|
|
90
|
Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity.
|
Med Dosim
|
2009
|
0.75
|
|
91
|
Bilateral extraocular muscles metastases from a choroidal melanoma.
|
Can J Ophthalmol
|
2013
|
0.75
|
|
92
|
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
|
Cancer J
|
2016
|
0.75
|
|
93
|
Image guidance in non-small cell lung cancer.
|
Semin Radiat Oncol
|
2010
|
0.75
|
|
94
|
A randomized controlled trial of lorazepam to reduce liver motion in patients receiving upper abdominal radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.75
|